UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002349
Receipt number R000002854
Scientific Title Evaluation of Trastuzumab without Chemotherapy as a Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients: Randomized Controlled Trial
Date of disclosure of the study information 2009/09/01
Last modified on 2020/10/28 15:57:31

No. Disposal Last modified on Item of update
1 Insert 2009/08/18 17:39:31
2 Update 2009/09/01 15:01:53 Recruitment status
3 Update 2010/11/01 11:18:30 UMIN ID1
4 Update 2010/11/01 11:22:39 Name of person sending information
Organization
Division name
Address
Email
5 Update 2011/06/27 16:23:16 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Institute
Institute
Post marketing survey by drug manufacture etc., specified by Japanese law.
6 Update 2011/06/28 10:08:08 Division name
7 Update 2011/06/29 10:09:21 Division name
Institute
8 Update 2012/04/17 13:28:17 Interventions/Control_2
Interventions/Control_2
Key inclusion criteria
Key inclusion criteria
9 Update 2012/04/17 13:33:32 Organization
Organization
Division name
Division name
Address
Address
Last name of contact person
Last name of contact person
10 Update 2012/09/10 11:38:28 Name of person sending information
Name of person sending information
11 Update 2013/05/31 13:50:35 Organization
Organization
Organization
12 Update 2013/06/17 09:23:12 Last name of contact person
Last name of contact person
Name of person sending information
Name of person sending information
13 Update 2013/06/17 09:23:45 Anticipated trial start date
Last follow-up date
14 Update 2014/11/17 10:18:35 Recruitment status
15 Update 2016/02/19 14:48:27 TEL
Email
Division name
Division name
16 Update 2017/07/31 12:07:55 Organization
Organization
Address
Email
Name of primary person or sponsor
Organization
Organization1
Address1
Tel1
Email1
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
17 Update 2017/08/01 15:01:37 Interventions/Control_2
Interventions/Control_2
18 Update 2017/08/01 15:21:35 Institutions
19 Update 2018/10/12 13:36:03 Public title
20 Update 2019/10/18 13:40:12 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Email
Organization
Organization
Address
Address
Tel
Email
21 Update 2019/10/18 13:55:51 Date of IRB
Date of closure to data entry
Date trial data considered complete
22 Update 2020/10/28 10:25:36 Recruitment status
23 Update 2020/10/28 15:57:02 Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
24 Update 2020/10/28 15:57:31 Recruitment status